Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionRecombinant coagulation Factor IX (rFIX)
Molecular Target Factor IX
Mechanism of ActionFactor IX replacement
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsContinuous prophylactic treatment of bleeding in patients with hemophilia B; Treat and prevent bleeding in patients with hemophilia B
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today